Company / Profit Margin
Moderna Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-145.2%
FY2025
5-year range
-856.7% / -68.8%
FY2021-FY2025
Trend
-31.9%
vs FY2024
Sector context
#103 of 146
Health Care
What the data says
At -145.2%, Moderna's profit margin ranks #103 of 146 in the Health Care sector. Profit Margin has fluctuated over the past 10 years, ranging from -856.7% in FY2021 to -68.8% in FY2023.
Based on SEC 10-K filings.
-145.2% in FY2025 with a 5-year CAGR of -52.1%.
Declined from -68.8% to -145.2% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -52.1pp
- 5-Year Change
- -52.1pp
- 10-Year Change
- -
Sector benchmark
#103 of 146 in Health CareTop 71% of 146This company -145.2% Sector average -796.3%
▼
+81.8% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 31.9% year-over-year.
- Currently 651.1pp above the Health Care sector average.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -145.2% | -31.9% |
| FY2024 | -110.0% | -59.8% |
| FY2023 | -68.8% | +26.0% |
| FY2022 | -93.0% | +89.1% |
| FY2021 | -856.7% | -820.9% |
| FY2020 | -93.0% | +89.1% |
| FY2019 | -856.7% | -200.8% |
| FY2018 | -284.8% | -129.1% |
| FY2017 | -124.3% | +37.7% |
| FY2016 | -199.5% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026